Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Countries
Countries
USA
Products 81 to 90 of 188
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Flax (non-transgenic, glyphosate tolerant)
by
Cibus
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Canada
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/28 16:45 (6 years ago)
Known funding amount:
70,000,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Orbella (Fragrant Moss)
by
Taxa
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/02 11:41 (6 years ago)
Known funding amount:
909,000 USD
Funding types:
Crowdfunding
+
Private Funding
Industry:
Health
Market status:
No longer on the market
Organization type(s):
Private Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Friendly Aedes Mosquito
by
Oxitec
Biotech components:
Animal
Business models:
B2B
Country of production:
UK
Country of distribution:
England
+
USA
Intended consumer:
Government
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
36,300,000 USD
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Other
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Fuelzyme 650 Alpha-amylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Europe
+
Asia
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 15:45 (5 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Fumaric Acid
by
GC Innovation America
+
Myriant
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/13 15:29 (6 years ago)
Known funding amount:
110,000,000 USD
Funding types:
Government
+
Venture Capital
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
GE Miniswine (Lab Animal)
by
Exemplar Genetics
Biotech components:
Animal
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Science
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
XON
(BYSE)
Value chain stage:
Finished Product
Gelatin
by
Geltor
Biotech components:
Bacteria
+
Yeast
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/19 16:01 (6 years ago)
Known funding amount:
2,500,000 USD
Funding types:
Private Funding
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Additive
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Gen 3 technical and medical fiber
by
Kraig Biocraft Laboratories
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
1,200,000 USD
Funding types:
Shareholder Investment
+
Government
Industry:
Medical
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
Web search
Trading symbol:
KBLB
(OTCQB)
Value chain stage:
Input
Gene-edited Produce
by
Pairwise Plants
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:49 (6 years ago)
Known funding amount:
125,000,000 USD
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Genetic Circuits
by
MIT
Biotech components:
Virus
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
University
+
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
1
…
4
5
6
7
8
9
10
11
12
13
…
19
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
